The store will not work correctly when cookies are disabled.
(2R)-2-Amino-1-(4-benzylpiperidin-1-yl)-3-hydroxypropan-1-one
ID: ALA4765058
PubChem CID: 162661606
Max Phase: Preclinical
Molecular Formula: C15H22N2O2
Molecular Weight: 262.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N[C@H](CO)C(=O)N1CCC(Cc2ccccc2)CC1
Standard InChI: InChI=1S/C15H22N2O2/c16-14(11-18)15(19)17-8-6-13(7-9-17)10-12-4-2-1-3-5-12/h1-5,13-14,18H,6-11,16H2/t14-/m1/s1
Standard InChI Key: VVWRZEHLCBVZES-CQSZACIVSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
4.7402 -10.4137 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4472 -10.0040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1556 -10.4115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4459 -9.1868 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8626 -10.0018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1569 -11.2287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8652 -11.6362 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0338 -10.0025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3288 -10.4087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3259 -11.2262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0341 -11.6359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7452 -11.2280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6173 -11.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9105 -11.2231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9146 -10.4060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2087 -9.9959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4991 -10.4030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4999 -11.2244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2064 -11.6308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 2 0
3 5 1 6
3 6 1 0
6 7 1 0
1 8 1 0
1 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
10 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 262.35 | Molecular Weight (Monoisotopic): 262.1681 | AlogP: 0.79 | #Rotatable Bonds: 4 |
Polar Surface Area: 66.56 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.84 | CX LogP: 0.73 | CX LogD: 0.16 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.84 | Np Likeness Score: -0.26 |
References
1. Yamada Y,Takashima H,Walmsley DL,Ushiyama F,Matsuda Y,Kanazawa H,Yamaguchi-Sasaki T,Tanaka-Yamamoto N,Yamagishi J,Kurimoto-Tsuruta R,Ogata Y,Ohtake N,Angove H,Baker L,Harris R,Macias A,Robertson A,Surgenor A,Watanabe H,Nakano K,Mima M,Iwamoto K,Okada A,Takata I,Hitaka K,Tanaka A,Fujita K,Sugiyama H,Hubbard RE. (2020) Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity., 63 (23): [PMID:33210531] [10.1021/acs.jmedchem.0c01215] |